Watch for Patients Taking the New Oral Multiple Sclerosis Meds

You'll see new ORAL meds to treat multiple sclerosis (MS) hit home med lists.

We're used to seeing the injectables (Avonex, Copaxone, etc) first-line. Or patients with more severe disease may jump right to a monoclonal antibody IV infusion (Lemtrada, Tysabri, etc).

But watch for the new options when patients prefer an oral med...or don't tolerate injectables.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote